NCT03979417View on ClinicalTrials.gov

Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets

CompletedOBSERVATIONAL

Enrollment

14

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

October 26, 2022

Conditions

HepatopathyFibrosis

Interventions

OTHER

Blood draw and liver resection

The samples are transferred to the research unit for immunological studies.

Trial Locations (2)

75013

Pitie-Salpetriere Hospital, Paris

75014

Cochin Hospital, Paris

Sponsors

Lead Sponsor

Institut Pasteur

All Listed Sponsors

lead

Institut Pasteur

INDUSTRY

NCT03979417 - Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets | Biotech Hunter | Biotech Hunter